Results of tadalafil treatment in patients following an open nerve-sparing radical prostatectomy
Özet
Purpose: To evaluate the effect of postoperatively administering a low daily dose of tadalafil on the erectile function of patients who underwent a nerve-sparing radical prostatectomy(NSRP) due to localized prostate cancer (PCa). Materials and Methods: Of 138 patients, who underwent NSRP due to PCa between 2012 and 2014, 55 patients who had not had pre-operative erectile dysfunction (ED) were included in the study. The mean age of the patients was 64 (54-72). On the 15th day after surgery, after ultrasound evaluation, all 55 patients started on a daily dose of 5 mg tadalafil that was continued for 2.5 months. The erectile function of patients was evaluated pre-operatively, post-operatively, and at the 3rd and 6th month after surgery using the International Index of Erectile Function (IIEF-5) test. None of the patients was treated with hormonal therapy or radiotherapy before or after surgery. Results: Three patients were excluded from the study due to the adverse effects of tadalafil and two patients elected to discontinue the treatment. Of the remaining 50 patients whose pre-operative erectile function had been found normal, at 3 months after surgery, 36 (72%) had normal erectile function; of the remaining patients in the study six (12%) presented with mild, two (4%) with moderate, and six (12%) with severe ED. Six months after surgery, 35 patients (70%) had normal erectile function while seven (14%) had mild, three (6%) moderate and five (10%) severe ED. There was no statistically significant difference between the results obtained at the 3rd and 6thmonth follow-up (p > 0.05). Three patients reported adverse effects with tadalafil including flushes in 2 (3.6%) and a headache in 1 (1.8%). Conclusions: The administration of a 5 mg post-operative dose of tadalafil to patients that had undergone a bilateral NSRP was found to have a positive effect on the recovery and maintenance of erectile function. However, there is still a need to investigate a larger series of cases.
Anahtar Kelimeler
Tam Kayıt
| Alan | Değer | Dil |
|---|---|---|
| dc.contributor.author | Hirik, Erkan | |
| dc.contributor.author | Bozkurt, Aliseydi | |
| dc.contributor.author | Karabakan, Mehmet | |
| dc.contributor.author | Onuk, Özkan | |
| dc.contributor.author | Balci, Mustafa Bahadir Can | |
| dc.contributor.author | Aydin, Memduh | |
| dc.contributor.author | Çakan, Murat | |
| dc.contributor.author | Nuhoglu, Baris | |
| dc.date.accessioned | 2026-10-18T20:30:18.543414852Z | |
| dc.date.available | 2026-10-18T20:30:18.543414852Z | |
| dc.date.issued | 2016 | |
| dc.description.abstract | Purpose: To evaluate the effect of postoperatively administering a low daily dose of tadalafil on the erectile function of patients who underwent a nerve-sparing radical prostatectomy(NSRP) due to localized prostate cancer (PCa). Materials and Methods: Of 138 patients, who underwent NSRP due to PCa between 2012 and 2014, 55 patients who had not had pre-operative erectile dysfunction (ED) were included in the study. The mean age of the patients was 64 (54-72). On the 15th day after surgery, after ultrasound evaluation, all 55 patients started on a daily dose of 5 mg tadalafil that was continued for 2.5 months. The erectile function of patients was evaluated pre-operatively, post-operatively, and at the 3rd and 6th month after surgery using the International Index of Erectile Function (IIEF-5) test. None of the patients was treated with hormonal therapy or radiotherapy before or after surgery. Results: Three patients were excluded from the study due to the adverse effects of tadalafil and two patients elected to discontinue the treatment. Of the remaining 50 patients whose pre-operative erectile function had been found normal, at 3 months after surgery, 36 (72%) had normal erectile function; of the remaining patients in the study six (12%) presented with mild, two (4%) with moderate, and six (12%) with severe ED. Six months after surgery, 35 patients (70%) had normal erectile function while seven (14%) had mild, three (6%) moderate and five (10%) severe ED. There was no statistically significant difference between the results obtained at the 3rd and 6thmonth follow-up (p > 0.05). Three patients reported adverse effects with tadalafil including flushes in 2 (3.6%) and a headache in 1 (1.8%). Conclusions: The administration of a 5 mg post-operative dose of tadalafil to patients that had undergone a bilateral NSRP was found to have a positive effect on the recovery and maintenance of erectile function. However, there is still a need to investigate a larger series of cases. | |
| dc.identifier.doi | 10.4081/aiua.2016.1.4 | |
| dc.identifier.eissn | 2282-4197 | |
| dc.identifier.endpage | 6 | |
| dc.identifier.issn | 1124-3562 | |
| dc.identifier.issue | 1 | |
| dc.identifier.pmid | 27072168 | |
| dc.identifier.scopus | 2-s2.0-84977765551 | |
| dc.identifier.startpage | 4 | |
| dc.identifier.uri | https://rdlopen.rawdatalibrary.net/r/ebyu/15464 | |
| dc.identifier.volume | 88 | |
| dc.identifier.wos | WOS:000406050000002 | |
| dc.language.iso | en | |
| dc.publisher | Edizioni Scripta Manent s.n.c. | |
| dc.relation.ispartof | Archivio Italiano di Urologia e Andrologia | |
| dc.rights | info:eu-repo/semantics/openAccess | |
| dc.subject | Erectile function. | |
| dc.subject | Radical prostatectomy | |
| dc.subject | Tadalafil | |
| dc.subject | Aged | |
| dc.subject | Erectile Dysfunction | |
| dc.subject | Humans | |
| dc.subject | Male | |
| dc.subject | Middle Aged | |
| dc.subject | Penile Erection | |
| dc.subject | Phosphodiesterase 5 Inhibitors | |
| dc.subject | Prostatectomy | |
| dc.subject | Prostatic Neoplasms | |
| dc.subject | Treatment Outcome | |
| dc.subject | phosphodiesterase V inhibitor | |
| dc.subject | adult | |
| dc.subject | Article | |
| dc.subject | disease severity | |
| dc.subject | drug efficacy | |
| dc.subject | drug safety | |
| dc.subject | follow up | |
| dc.subject | headache | |
| dc.subject | hot flush | |
| dc.subject | human | |
| dc.subject | low drug dose | |
| dc.subject | major clinical study | |
| dc.subject | nerve sparing radical prostatectomy | |
| dc.subject | penis erection | |
| dc.subject | postoperative care | |
| dc.subject | postoperative period | |
| dc.subject | preoperative evaluation | |
| dc.title | Results of tadalafil treatment in patients following an open nerve-sparing radical prostatectomy | |
| dc.type | Article | |
| dspace.entity.type | Publication | |
| rdl.citation.scopus | 1 | |
| rdl.citation.wos | 0 | |
| rdl.department | Erzincan University Mengücek Gazi Education and Research Hospital, Urology Clinic. ehirik@gmail.com. | |
| rdl.oa.status | gold | |
| rdl.source.index | SCOPUS | |
| rdl.source.index | WOS | |
| rdl.source.index | PUBMED | |
| rdl.wos.index | Emerging Sources Citation Index (ESCI) |
